Scientific reports · 2025
Boric acid-functionalized bentonite nanostructures attenuated paraquat-induced pulmonary injuries in rats.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Talebian Asma, Soltani Motahareh, Karami-Mohajeri Somayyeh, Jafari Elham, Ahmadi Jafar, Ranjbar Mehdi, Abedi Fatemeh, Mandegary Ali
Аннотация
This study evaluated the antioxidant, anti-inflammatory, and anti-fibrotic effects of boric acid-functionalized bentonite nanostructures (BABTs) in a rat model of paraquat (PQ)-induced pulmonary toxicity, a well-established model for herbicide-related lung fibrosis. BABTs (20-60 nm) were synthesized via a microwave-assisted technique, characterized by dynamic light scattering, scanning electron microscopy, Fourier-transform infrared, and ultraviolet-visible spectroscopy, confirming PQ-BABT complex formation. Forty-eight male Wistar rats were randomized into eight groups (n = 6/group): negative control (saline), positive control (single 100 mg/kg PQ oral dose), and experimental groups receiving BABTs or boric acid (BA) at 10, 50, or 100 mg/kg/day orally, 30 min post-PQ. After 14 days, lung malondialdehyde (MDA) levels and histopathological changes (H&E, Masson's Trichrome) were assessed. BABTs at 50 mg/kg significantly decreased lung malondialdehyde (MDA) levels (P < 0.05) and significantly attenuated tissue injury (P < 0.05), suggesting an attenuation of oxidative stress, inflammation, and fibrosis, while boric acid (BA) demonstrated no significant effect. BABTs mitigate PQ-induced lung injury through antioxidant, anti-inflammatory, and anti-fibrotic mechanisms, enhanced by reducing PQ bioavailability. These findings position BABTs as a promising therapeutic candidate for PQ-induced pulmonary fibrosis, warranting further clinical evaluation.